The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts.
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech; Lilly
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Ben George
Consulting or Advisory Role - Celgene; Cook Medical
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Mark Emery Johns
No Relationships to Disclose
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene; Genentech; Merrimack; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Incyte; PRISM Pharma; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Celgene; Celgene
 
Eunice Lee Kwak
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen
 
Aparna Kalyan
Research Funding - Bristol-Myers Squibb (Inst)
 
Victoria Manax
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Moncy Ye
No Relationships to Disclose
 
Tianlei Chen
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Nataliya Trunova
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Peter J. O'Dwyer
Consulting or Advisory Role - Bristol-Myers Squibb; Five Prime Therapeutics; Forty Seven; Genentech
Research Funding - BBI Healthcare; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer